Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer
Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer
This trial will facilitate access to denosumab for adults with advanced cancer who have participated in a denosumab phase 3 study until denosumab is approved and available for sale.
Inclusion Criteria:
Exclusion Criteria:
Capital Federal, Buenos Aires C1426ANZ, Argentina
Kure-shi, Hiroshima 737-0023, Japan
Isehara-shi, Kanagawa 259-1193, Japan
Kitaadachi-gun, Saitama 362-0806, Japan
Chuo-ku, Tokyo 104-0045, Japan
Krasnogorsky District, 143423, Russia